Healthcare IT News December 4, 2020
Experts call the logistics of getting doses into the hands of distributors a “phenomenally critical” challenge – and not one that’s easily solved.
As Pfizer and Moderna wait for the U.S. Federal and Drug Administration to issue an emergency use authorization for their respective vaccines, the importance of a seamless – or at least well-connected – supply chain has become increasingly clear.
According to the U.S. Department of Health and Human Services, the first rollout of the vaccine is likely to be very limited, with state governors and public health departments directing allocation of the first available doses.
But if plans to produce tens of millions of doses by the end of 2020 see fruition, professionals say logistics will...
Today's Sponsors
Today's Sponsor